Healthpeak Properties (NYSE:DOC) Price Target Raised to $24.00

Healthpeak Properties (NYSE:DOC) had its price objective increased by Robert W. Baird from $21.00 to $24.00 in a research report released on Thursday morning,Benzinga reports. They currently have an outperform rating on the real estate investment trust’s stock.

Several other research firms have also recently issued reports on DOC. Scotiabank increased their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a report on Wednesday, May 27th. Mizuho upped their target price on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, July 6th. UBS Group increased their price target on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Citigroup lifted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Tuesday. Finally, Barclays started coverage on Healthpeak Properties in a research note on Tuesday, July 7th. They issued an “equal weight” rating and a $23.00 price objective on the stock. Four investment analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $21.44.

Healthpeak Properties Stock Performance

DOC stock opened at $20.78 on Thursday. The company has a 50-day simple moving average of $21.33 and a 200 day simple moving average of $18.90. The company has a market capitalization of $14.33 billion, a P/E ratio of 59.38, a PEG ratio of 3.20 and a beta of 1.01. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $22.95.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm had revenue of $771.58 million for the quarter, compared to analysts’ expectations of $725.64 million. During the same quarter last year, the company earned $0.46 EPS. Healthpeak Properties’s quarterly revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Sell-side analysts predict that Healthpeak Properties will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be given a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s dividend payout ratio is 348.57%.

Institutional Trading of Healthpeak Properties

Several institutional investors have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC increased its stake in Healthpeak Properties by 7.3% in the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock valued at $366,000 after buying an additional 1,231 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Healthpeak Properties by 110.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after buying an additional 63,930 shares during the period. Woodline Partners LP grew its holdings in shares of Healthpeak Properties by 41.3% during the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after acquiring an additional 17,279 shares in the last quarter. Brown Advisory Inc. grew its holdings in shares of Healthpeak Properties by 3.1% during the 2nd quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after acquiring an additional 1,415 shares in the last quarter. Finally, Qube Research & Technologies Ltd acquired a new position in shares of Healthpeak Properties in the second quarter worth $3,117,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.